09 Jan 2025 | 04:00 PM GMT

Masterclass: Highlights From The 2024 DTA Summit

Participants:

Andy Molnar CEODigital Therapeutics Alliance
Andy Molnar
CEODigital Therapeutics Alliance
Lani Reilly VP Patient AccessDigital Therapeutics Alliance
Lani Reilly
VP Patient AccessDigital Therapeutics Alliance
Alice Murphy Community ManagerHLTH
Alice Murphy
Community ManagerHLTH
Arun Bhatia Commercial Strategy Lead - Digital HealthAstellas Pharma Rx+ Business Accelerator
Arun Bhatia
Commercial Strategy Lead - Digital HealthAstellas Pharma Rx+ Business Accelerator
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
Imogen Marouillat Head of Solution DeliveryMerck
Imogen Marouillat
Head of Solution DeliveryMerck
Jorge Juan Fernández García Chief Innovation OfficerHospital Clínic Barcelona
Jorge Juan Fernández García
Chief Innovation OfficerHospital Clínic Barcelona
Larry Taylor Director of Insights and AdvisoryHLTH Inc.
Larry Taylor
Director of Insights and AdvisoryHLTH Inc.
Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC
Sarah Houy Founder, CEOSentur
Sarah Houy
Founder, CEOSentur
Stephen Dunne Chief Product & Technology Officer - ManagingKoa Health
Stephen Dunne
Chief Product & Technology Officer - ManagingKoa Health
Susanne Gruber Strategic Advisor, Interim ExecutiveIgnited Vision
Susanne Gruber
Strategic Advisor, Interim ExecutiveIgnited Vision
Taiba Quraishi Innovation Accelerator LeadAlexion Pharmaceuticals
Taiba Quraishi
Innovation Accelerator LeadAlexion Pharmaceuticals

About this Meeting

The Digital Therapeutics Alliance (DTA) will present key highlights and insights from their landmark 2024 Summit. This gathering brought together industry leaders, healthcare innovators, and policymakers to address critical developments in the digital therapeutics landscape. The summit's unique focus on commercialization challenges, combined with interactive workshops and thought leadership sessions, provided valuable insights into the future of DTx implementation and adoption.


The summit's emphasis on practical implementation strategies, regulatory frameworks, and market access solutions offers valuable lessons for organizations looking to advance their digital therapeutic initiatives.


Join us to discuss:


  1. What key commercialization strategies and solutions emerged from the summit's interactive workshops and expert presentations?
  2. How are industry leaders addressing the challenges of DTx integration and adoption, as highlighted by speakers from Banner Health, Point32Health, and other participating organizations?
  3. What insights can we gain from the summit's discussions about the future of DTx reimbursement models and regulatory frameworks, particularly given the participation of HHS representatives?